Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 10.99M | $53.0M | 15.00% | +2.75M | 2026-03-31 |
| RTW INVESTMENTS, LP | 6.42M | $31.0M | 8.77% | -- | 2026-03-31 |
| ACORN CAPITAL ADVISORS, LLC | 3.50M | $17.0M | 4.77% | +917.4K | 2026-03-31 |
| BlackRock, Inc. | 3.11M | $15.0M | 4.24% | +247.4K | 2026-03-31 |
| Saturn V Capital Management LP | 2.90M | $14.0M | 3.95% | -- | 2026-03-31 |
| Portolan Capital Management, LLC | 2.89M | $14.0M | 3.95% | +1.20M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.46M | $12.0M | 3.36% | -- | 2026-03-31 |
| Vestal Point Capital, LP | 1.13M | $5.0M | 1.54% | -- | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 1.06M | $5.0M | 1.45% | +923.4K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.04M | $5.0M | 1.41% | +57.9K | 2026-03-31 |
